Junshi Biosciences released its semi-annual report for 2026, achieving operating revenue of 1.696 billion yuan, up 45.18 percent year on year. Net profit attributable to shareholders of the listed company was 21.663 million yuan, turning from a loss to a profit compared with the same period last year. Among this, second-quarter net profit was 42 million yuan, while first-quarter net profit was negative 21 million yuan, also turning from a loss to a profit on a quarter-on-quarter basis.
Shanghai Junshi Biosciences Co LtdJunshi Biosciences reported a net profit of 21.663 million yuan in H1 2026, turning from a loss to a profit, with revenue up 45.18% year-on-year.
